关注
Bruce Kirenga
Bruce Kirenga
Chief Research Scientist and Director Makerere University Lung Institute
在 chs.mak.ac.ug 的电子邮件经过验证
标题
引用次数
引用次数
年份
Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis
BM Mayosi, M Ntsekhe, J Bosch, S Pandie, H Jung, F Gumedze, J Pogue, ...
New England Journal of Medicine 371 (12), 1121-1130, 2014
3022014
Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study
F van Gemert, B Kirenga, N Chavannes, M Kamya, S Luzige, P Musinguzi, ...
The Lancet Global Health 3 (1), e44-e51, 2015
2362015
Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis
KP Fennelly, EC Jones-López, I Ayakaka, S Kim, H Menyha, B Kirenga, ...
American journal of respiratory and critical care medicine 186 (5), 450-457, 2012
1942012
Association between household air pollution exposure and chronic obstructive pulmonary disease outcomes in 13 low-and middle-income country settings
T Siddharthan, MR Grigsby, D Goodman, M Chowdhury, A Rubinstein, ...
American journal of respiratory and critical care medicine 197 (5), 611-620, 2018
1642018
Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control
BJ Kirenga, W Ssengooba, C Muwonge, L Nakiyingi, S Kyaligonza, ...
BMC public health 15, 1-7, 2015
1412015
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective …
SG Mfinanga, BJ Kirenga, DM Chanda, B Mutayoba, T Mthiyane, G Yimer, ...
The Lancet infectious diseases 14 (7), 563-571, 2014
1322014
Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing
TG Clark, K Mallard, F Coll, M Preston, S Assefa, D Harris, S Ogwang, ...
PloS one 8 (12), e83012, 2013
952013
Long term complications after completion of pulmonary tuberculosis treatment: a quest for a public health approach
J Chakaya, B Kirenga, H Getahun
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 3, 10-12, 2016
852016
Predictors and outcomes of mycobacteremia among HIV-infected smear-negative presumptive tuberculosis patients in Uganda
L Nakiyingi, W Ssengooba, D Nakanjako, D Armstrong, M Holshouser, ...
BMC infectious Diseases 15, 1-8, 2015
512015
Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study
BJ Kirenga, J Levin, I Ayakaka, W Worodria, N Reilly, F Mumbowa, ...
PLoS One 9 (3), e90614, 2014
502014
Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2× 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone …
BM Mayosi, M Ntsekhe, J Bosch, J Pogue, F Gumedze, M Badri, H Jung, ...
American heart journal 165 (2), 109-115. e3, 2013
462013
系统目前无法执行此操作,请稍后再试。
文章 1–11